Hot Pursuit     22-May-24
Granules India Ltd spurts 3.42%, up for five straight sessions
Granules India Ltd is quoting at Rs 423.1, up 3.42% on the day as on 12:44 IST on the NSE. The stock is up 53.38% in last one year as compared to a 22.96% gain in NIFTY and a 56.21% gain in the Nifty Pharma.

Granules India Ltd rose for a fifth straight session today. The stock is quoting at Rs 423.1, up 3.42% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 22561.15. The Sensex is at 74053.66, up 0.14%. Granules India Ltd has added around 2.07% in last one month.

Meanwhile, Nifty Pharma index of which Granules India Ltd is a constituent, has added around 4.19% in last one month and is currently quoting at 19205.2, up 0.16% on the day. The volume in the stock stood at 22.96 lakh shares today, compared to the daily average of 8.96 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 423.6, up 3.3% on the day. Granules India Ltd is up 53.38% in last one year as compared to a 22.96% gain in NIFTY and a 56.21% gain in the Nifty Pharma index.

The PE of the stock is 22.74 based on TTM earnings ending March 24.

Previous News
  Granules India Ltd up for third consecutive session
 ( Hot Pursuit - 01-Oct-24   13:05 )
  Granules India unveils its Mobile Cancer Screening Unit at AIG Hospitals
 ( Corporate News - 24-Sep-24   14:40 )
  Granules India Ltd drops for fifth straight session
 ( Hot Pursuit - 17-Sep-24   13:35 )
  Granules India's Gagillapur FD facility completes USFDA inspection
 ( Corporate News - 12-Sep-24   15:19 )
  Granules India tumbles after Hyderabad facility gets six observations from USFDA
 ( Hot Pursuit - 12-Sep-24   15:15 )
  Granules India Ltd leads losers in 'A' group
 ( Hot Pursuit - 12-Sep-24   15:00 )
  Granules India’s Gagillapur facility completes USFDA inspection with 6 observations
 ( Hot Pursuit - 09-Sep-24   10:30 )
  Granules India Ltd soars 1.63%, up for third straight session
 ( Hot Pursuit - 21-Aug-24   13:05 )
  Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution
 ( Corporate News - 20-Aug-24   15:24 )
  Granules India rises on USFDA nod for oral drug Glycopyrrolate
 ( Hot Pursuit - 20-Aug-24   14:00 )
  Granules India receives US FDA nod for depression treatment drug Trazodone
 ( Hot Pursuit - 09-Aug-24   14:52 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top